Gérald Massonnet

599 total citations
10 papers, 482 citations indexed

About

Gérald Massonnet is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gérald Massonnet has authored 10 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Gérald Massonnet's work include Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers) and Ocular Oncology and Treatments (3 papers). Gérald Massonnet is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers) and Ocular Oncology and Treatments (3 papers). Gérald Massonnet collaborates with scholars based in France, United States and Germany. Gérald Massonnet's co-authors include Christine Chomienne, Sophie Richon, Joseph Saliba, Jean-Paul Beressi, Benjamin Manéglier, Els Verhoeyen, Stany Chrétien, Francis Relouzat, Philippe Rousselot and Victoria Raggueneau and has published in prestigious journals such as Nature, PLoS ONE and Cancer Research.

In The Last Decade

Gérald Massonnet

9 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gérald Massonnet France	9	208	192	126	84	80	10	482
Melanie Janning Germany	14	266 1.3×	320 1.7×	98 0.8×	208 2.5×	104 1.3×	33	746
Natalia Baran United States	15	380 1.8×	153 0.8×	244 1.9×	204 2.4×	55 0.7×	62	679
Latha Sridharan United States	10	222 1.1×	367 1.9×	77 0.6×	37 0.4×	45 0.6×	11	656
Ján Gurský Czechia	13	271 1.3×	137 0.7×	55 0.4×	99 1.2×	34 0.4×	22	466
Yvette van Hensbergen Netherlands	12	301 1.4×	348 1.8×	132 1.0×	155 1.8×	21 0.3×	22	666
Nicole E. McNeil United States	12	312 1.5×	223 1.2×	82 0.7×	107 1.3×	19 0.2×	23	623
Douglas D. Fang China	12	333 1.6×	408 2.1×	47 0.4×	146 1.7×	29 0.4×	33	632
Bernd Muehlenweg Germany	14	232 1.1×	171 0.9×	123 1.0×	294 3.5×	25 0.3×	19	555
Wade Anderson United States	4	284 1.4×	210 1.1×	299 2.4×	91 1.1×	37 0.5×	7	673
Jenny E. Chu Canada	7	289 1.4×	444 2.3×	26 0.2×	184 2.2×	67 0.8×	15	619

Countries citing papers authored by Gérald Massonnet

Since Specialization

Citations

This map shows the geographic impact of Gérald Massonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Massonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Massonnet more than expected).

Fields of papers citing papers by Gérald Massonnet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérald Massonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Massonnet. The network helps show where Gérald Massonnet may publish in the future.

Co-authorship network of co-authors of Gérald Massonnet

This figure shows the co-authorship network connecting the top 25 collaborators of Gérald Massonnet. A scholar is included among the top collaborators of Gérald Massonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérald Massonnet. Gérald Massonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Decaudin, Didier, Rania El Botty, Gérald Massonnet, et al.. (2018). Selumetinib-based therapy in uveal melanoma patient-derived xenografts. Oncotarget. 9(31). 21674–21686. 18 indexed citations

Gentien, David, A Duché, Audrey Rapinat, et al.. (2017). Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient‐derived xenografts. Pigment Cell & Melanoma Research. 30(3). 317–327. 24 indexed citations

Bougherara, Houcine, Fariba Némati, Nicolás André, et al.. (2017). The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages. Oncotarget. 8(59). 99950–99965. 16 indexed citations

Massonnet, Gérald, David Gentien, Zofia Maciorowski, et al.. (2016). Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization. PLoS ONE. 11(7). e0157670–e0157670. 9 indexed citations

Massonnet, Gérald, Rania El Botty, Sergio Roman‐Roman, et al.. (2016). Abstract 2087: The MEK1/2 inhibitor selumetinib (AZD6244; ARRY-142886) appears as an efficient targeted therapy when used in an adjuvant setting in patient-derived xenografts of uveal melanoma. Cancer Research. 76(14_Supplement). 2087–2087.

Nunes, Manoel, Patricia Vrignaud, Sophie Vacher, et al.. (2015). Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data. Cancer Research. 75(8). 1560–1566. 56 indexed citations

Prost, Stéphane, Francis Relouzat, Marc Spentchian, et al.. (2015). Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists. Nature. 525(7569). 380–383. 218 indexed citations

Stimmer, Lev, Fariba Némati, Gérald Massonnet, et al.. (2014). Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds. BMC Cancer. 14(1). 916–916. 34 indexed citations

Weiswald, Louis‐Bastien, Sophie Richon, Gérald Massonnet, et al.. (2013). A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation. British Journal of Cancer. 108(8). 1720–1731. 43 indexed citations

10.

Weiswald, Louis‐Bastien, Sophie Richon, Pierre Validire, et al.. (2009). Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness. British Journal of Cancer. 101(3). 473–482. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact